A review article on transethosomes: revolutionizing drug delivery through transdermal patches.

IF 2.4 4区 医学 Q3 CHEMISTRY, MEDICINAL
Siddharam Loni, Suma U S, R Zohmingliani, Sumanth Sumanth
{"title":"A review article on transethosomes: revolutionizing drug delivery through transdermal patches.","authors":"Siddharam Loni, Suma U S, R Zohmingliani, Sumanth Sumanth","doi":"10.1080/03639045.2025.2507688","DOIUrl":null,"url":null,"abstract":"<p><p>Transethosomes, advanced nanovesicular carriers, have emerged as a revolutionary drug delivery system, particularly for transdermal patches. Combining the structural flexibility of ethosomes and the penetration-enhancing properties of surfactants, transethosomes offer remarkable advantages in overcoming the skin barrier to deliver a broad range of therapeutic agents. These vesicles enhance drug permeation, improve bioavailability, and enable controlled and sustained release, making them a promising alternative to conventional drug delivery methods. This review explores the unique composition, mechanisms of action, and penetration pathways of transethosomes while highlighting their application in various therapeutic areas, including pain management, dermatology, and hormone replacement therapies. Additionally, the article discusses the potential for transethosomes to target specific skin layers or cells, improving drug localization and minimizing systemic side effects. Current challenges, such as formulation stability, variability in skin types, and regulatory hurdles, are critically analyzed, alongside underexplored areas like large biomolecule delivery and multi-drug systems. Emerging trends, including personalized medicine, combination therapies, and stimuli-responsive formulations, are also reviewed, emphasizing the future potential of transethosomes in drug delivery innovation. By addressing these aspects, this article provides comprehensive insights into the transformative role of transethosomes in revolutionizing transdermal drug delivery systems.</p>","PeriodicalId":11263,"journal":{"name":"Drug Development and Industrial Pharmacy","volume":" ","pages":"691-701"},"PeriodicalIF":2.4000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Development and Industrial Pharmacy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/03639045.2025.2507688","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/27 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

Transethosomes, advanced nanovesicular carriers, have emerged as a revolutionary drug delivery system, particularly for transdermal patches. Combining the structural flexibility of ethosomes and the penetration-enhancing properties of surfactants, transethosomes offer remarkable advantages in overcoming the skin barrier to deliver a broad range of therapeutic agents. These vesicles enhance drug permeation, improve bioavailability, and enable controlled and sustained release, making them a promising alternative to conventional drug delivery methods. This review explores the unique composition, mechanisms of action, and penetration pathways of transethosomes while highlighting their application in various therapeutic areas, including pain management, dermatology, and hormone replacement therapies. Additionally, the article discusses the potential for transethosomes to target specific skin layers or cells, improving drug localization and minimizing systemic side effects. Current challenges, such as formulation stability, variability in skin types, and regulatory hurdles, are critically analyzed, alongside underexplored areas like large biomolecule delivery and multi-drug systems. Emerging trends, including personalized medicine, combination therapies, and stimuli-responsive formulations, are also reviewed, emphasizing the future potential of transethosomes in drug delivery innovation. By addressing these aspects, this article provides comprehensive insights into the transformative role of transethosomes in revolutionizing transdermal drug delivery systems.

透皮贴剂给药技术的研究进展。
透皮体作为一种先进的纳米囊泡载体,已经成为一种革命性的药物传递系统,特别是用于透皮贴剂。结合溶酶体的结构灵活性和表面活性剂的渗透增强特性,跨溶酶体在克服皮肤屏障以提供广泛的治疗药物方面具有显着的优势。这些囊泡增强药物渗透,提高生物利用度,并实现控制和持续释放,使其成为传统药物递送方法的有希望的替代方案。本文综述了跨体的独特组成、作用机制和渗透途径,同时强调了它们在各种治疗领域的应用,包括疼痛管理、皮肤病学和激素替代疗法。此外,本文还讨论了转运体靶向特定皮肤层或细胞的潜力,从而改善药物定位并最大限度地减少全身副作用。当前的挑战,如配方稳定性、皮肤类型的可变性和监管障碍,以及未开发的领域,如大生物分子递送和多药物系统,都进行了严格的分析。本文还回顾了包括个体化药物、联合疗法和刺激反应制剂在内的新兴趋势,强调了转运体在药物传递创新方面的未来潜力。通过解决这些方面,本文提供了全面的见解,转化体在革命性的透皮给药系统的变革作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.80
自引率
0.00%
发文量
82
审稿时长
4.5 months
期刊介绍: The aim of Drug Development and Industrial Pharmacy is to publish novel, original, peer-reviewed research manuscripts within relevant topics and research methods related to pharmaceutical research and development, and industrial pharmacy. Research papers must be hypothesis driven and emphasize innovative breakthrough topics in pharmaceutics and drug delivery. The journal will also consider timely critical review papers.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信